Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications
Elle Levit, Erin E. Longbrake, Sharon Stoll
Topics & Concepts
MedicineSeroconversionNatalizumabMultiple sclerosisImmunologyFingolimodVaccinationImmune systemRituximabOcrelizumabInternal medicineAntibodySARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research StudiesImmunotherapy and Immune Responses